{"transactions":[{"id":825386,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-03-30T17:29:05.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":47170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU has a value equal to one share of common stock. 25% of the RSUs vested on March 26, 2026 and the remaining 75% will vest in equal installments on each of the second-, third- and fourth-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU has a value equal to one share of common stock. 25% of the RSUs vested on March 26, 2026 and the remaining 75% will vest in equal installments on each of the second-, third- and fourth-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU has a value equal to one share of common stock. 25% of the RSUs vested on March 26, 2026 and the remaining 75% will vest in equal installments on each of the second-, third- and fourth-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."}],"balance_after":141509,"derivative":{"underlying":"Common Stock","underlying_shares":47170},"source":{"system":"sec-edgar","filing":"0001493152-26-013571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315226013571/ownership.xml","form_type":"4"}},{"id":825385,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-30T17:29:05.000Z","date":"2026-03-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":12310,"price":4.11,"value":50594.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported disposition reflects shares withheld by the Company to cover required tax withholding obligations upon the vesting of the RSUs. The reporting person did not sell any shares."}],"balance_after":38365,"source":{"system":"sec-edgar","filing":"0001493152-26-013571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315226013571/ownership.xml","form_type":"4"}},{"id":825384,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-30T17:29:05.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":47170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents vesting of restricted stock units (\"RSUs\") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs vested on the one-year anniversary of the effective date of grant."}],"balance_after":50675,"source":{"system":"sec-edgar","filing":"0001493152-26-013571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315226013571/ownership.xml","form_type":"4"}},{"id":1030646,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2025-09-30T16:05:30.000Z","date":"2025-09-28","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":400000,"derivative":{"exercise_price":3.33,"expiration_date":"2035-09-28","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-25-016291","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315225016291/ownership.xml","form_type":"4"}},{"id":1188947,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-03-28T16:05:16.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":188679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the restricted stock units will vest on each of the one-, two-, three- and four-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"25% of the restricted stock units will vest on each of the one-, two-, three- and four-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."}],"balance_after":188679,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":188679},"source":{"system":"sec-edgar","filing":"0001641172-25-001179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000164117225001179/ownership.xml","form_type":"4"}},{"id":1505770,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2024-05-22T16:56:24.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will vest and thereby be exercisable after one year of continuous service from the effective date of grant, and the balance will vest and thereby be exercisable in 36 equal monthly installments commencing one year after the date of grant, subject to continuous service through the applicable vesting date."}],"balance_after":90000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001493152-24-021047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315224021047/ownership.xml","form_type":"4"}},{"id":1542023,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock, no par value","published_at":"2024-04-15T06:04:01.000Z","date":"2024-04-11","kind":"purchase","planned":false,"acquired":true,"shares":3390,"price":2.95,"value":10000.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private offering."}],"balance_after":3505,"source":{"system":"sec-edgar","filing":"0001493152-24-014512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315224014512/ownership.xml","form_type":"4"}},{"id":1804015,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2023-08-17T18:57:33.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest and thereby be exercisable on December 31, 2025, based on achievement of certain specified targets with respect to the 30-day volume-weighted average price of Company's common stock, measured as of the end of each full calendar month up through December 31, 2025, subject to continuous services through December 31, 2025."}],"balance_after":40000,"derivative":{"exercise_price":3.34,"expiration_date":"2033-08-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-029347","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315223029347/ownership.xml","form_type":"4"}},{"id":1857489,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2023-06-13T16:05:32.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest and thereby be exercisable on December 31, 2025, based on achievement of certain specified targets with respect to the 30-day volume-weighted average price of Company's common stock, measured as of the end of each full calendar month up through December 31, 2025, subject to continuous services through December 31, 2025."}],"balance_after":800000,"derivative":{"exercise_price":0.2132,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001493152-23-021059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315223021059/ownership.xml","form_type":"4"}},{"id":1857488,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2023-06-13T16:05:32.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will vest and thereby be exercisable after one year of continuous service from the effective date of grant, and the balance will vest and thereby be exercisable in 36 equal monthly installments commencing one year after the date of grant, subject to continuous service through the applicable vesting date."}],"balance_after":350000,"derivative":{"exercise_price":0.2132,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-23-021059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315223021059/ownership.xml","form_type":"4"}},{"id":1987597,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-02-28T17:59:10.000Z","date":"2023-02-24","kind":"grant","acquired":true,"shares":116426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":116426,"derivative":{"exercise_price":0.39,"expiration_date":"2033-02-24","underlying":"Common Stock","underlying_shares":116426},"source":{"system":"sec-edgar","filing":"0001493152-23-006302","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315223006302/ownership.xml","form_type":"4"}},{"id":2051074,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55352,"kind":"person","name":"Riggs Josh","position":1,"cik":"0001956391","reported_name":"Riggs Josh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-01-19T17:18:27.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":257485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will become exercisable in three equal installments on each of January 17, 2024, January 17, 2025 and January 17, 2026, subject to continuous service through the applicable vesting date."}],"balance_after":257485,"derivative":{"exercise_price":0.4629,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":257485},"source":{"system":"sec-edgar","filing":"0001493152-23-001946","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1956391/000149315223001946/ownership.xml","form_type":"4"}}]}